Patients Comfort During Highflow Oxygen Therapy With Asymmetrical Prongs

Launched by UNIVERSITY OF PADOVA · Jan 11, 2025

Keywords

ClinConnect Summary

This clinical trial is studying how comfortable patients feel while using a high-flow nasal cannula (HFNC) for oxygen therapy. HFNC is a device that provides heated and humidified oxygen to help people with respiratory failure breathe better. The goal of the trial is to see if using a specific type of prong (called asymmetrical prongs) improves comfort compared to standard oxygen treatments or other methods.

To be eligible for this study, participants need to be adults over 18 years old who require oxygen support in an intensive care unit (ICU). However, individuals who are pregnant, have a tracheostomy (a surgical opening in the neck), or certain other medical conditions may not be able to participate. If you join the trial, you can expect to receive oxygen therapy through the HFNC and share your experiences about your comfort levels during the treatment. This research aims to improve the way we support patients with breathing difficulties in the future.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • - adult patients (\>18 years old) requiring oxygen support in the ICU
• Exclusion Criteria:
• • pregnancy;
• • presence of tracheostomy;
• • contraindications to EIT;
• • contraindications to HFNCs positioning,
• • clinical evidence of nare occlusion (patient will be asked to deeply inspire from the nose while researcher occludes manually each nostril alternately: if unable to breath from the free nare with the other one occluded, patient will not be eligible for participating to the study), or very small nare fitting only the S-sized Duet cannulas;
• • patients requiring nasogastric tubes for mandatory clinical reasons, i.e., delayed gastric emptying, upper abdominal surgery.